Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Prediction Raises $4.5M

NEW YORK (GenomeWeb) – Genomic Prediction has raised $4.5 million through the sale of preferred stock in a financing round led by Nimble Ventures, the company said today. New investor PeopleFund also joined with Genomic Prediction's early investors.

The North Brunswick, New Jersey-based firm offers tests geared toward patients undergoing in vitro fertilization. It offers a next-generation sequencing-based test for chromosomal aneuploidies, gSeq, as well as an NGS-based test to screen for monogenic and polygenic diseases, EPgT. The gSeq test costs $150 per patient plus an additional $200 for each embryo that is screened, while EPgT costs $1,000, plus $400 per embryo.

The company plans to use the funding to expand its sales team and to further invest in data science. The firm received approval from the New Jersey Department of Health Clinical Laboratory Improvement Services to offer its two preimplantation genetic tests for monogenic disorders and polygenic disorders last September.

"Our cost-effective methodology of polygenic scoring builds on old technology from industrial agriculture, but we are the first in history to develop this technology to protect the human embryo," Genomic Prediction CEO Laurent Tellier said in a statement.

The Scan

Fly Single-Nucleus Transcriptome Map Shows Effects of Aging

Researchers in Science present a single-nucleus transcriptome map of Drosophila melanogaster tissues from across its lifespan.

Maize Assembly Goes Telomere to Telomere

Researchers in Nature Genetics describe their telomere-to-telomere assembly of the 10 chromosomes of the Mo17 inbred maize line.

Functional Catalog of β-Sarcoglycan Alterations Aims to Help Interpret Uncertain Variants

A Journal of Clinical Investigation study examines the functional effects of gene alterations on the limb-girdle muscular dystrophy-linked β-sarcoglycan.

Vaginal Microbiota Transfers Boost C-Section Infants' Gut Microbiome Maturation

Vaginal microbiota transfers may also influence C-section newborns' early development, a new study in Cell Host & Microbe reports.